MedPath
NMPA Approval

Vedolizumab for injection

S20200006

March 11, 2020

Drug Information

注射用维得利珠单抗

安吉优

注射剂

300mg/瓶

生物制品

March 11, 2020

March 10, 2025

Company Information

Applicant Company

Takeda Pharma A/S

Delta Park 45, 2665 Vallensbaek Strand, Denmark

Manufacturing Company

4720 Mitsui,Yamaguchi Prefecture,743-8502 Hikari,Japan

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

注射用维得利珠单抗 - NMPA 批准文号 | MedPath